A vaccine strategy that protects against genital herpes by establishing local memory T cells

Nature

Volumn 491, Issue 7424, 2012, Pages 463-467

  Shin, Haina ^a   Iwasaki, Akiko ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; SITIMAGENE CERADENOVEC;

ANTIBODY; REPRODUCTIVE HEALTH; SECONDARY SEXUAL CHARACTERISTICS; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VACCINE; VIRAL DISEASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FATE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; FEMALE; FEMALE GENITAL SYSTEM; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IMMUNIZATION; INFLAMMATION; MEDIATOR; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE CELL; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBODIES, VIRAL; CELL COUNT; CHEMOKINE CXCL10; CHEMOKINE CXCL9; FEMALE; HERPES GENITALIS; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VACCINATION; VAGINA; VIRAL LOAD; VIRAL VACCINES;

HERPES; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; MUS;

EID: 84869082967     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11522     Document Type: Article

References (26)

1. McElrath, M. J. & Haynes, B. F. Induction ofimmunity to human immunodeficiency virus type-1 by vaccination. Immunity 33, 542-554 (2010).
2. Gebhardt, T. et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nature Immunol. 10, 524-530 (2009).
3. Jiang, X. et al. Skin infection generates non-migratory memory CD81 TRM cells providing global skin immunity. Nature 483, 227-231 (2012).
4. Nakanishi, Y., Lu, B., Gerard, C. & Iwasaki, A. CD81 T lymphocyte mobilization to virus-infected tissue requires CD41 T-cell help. Nature 462, 510-513 (2009).
5. Koelle, D. M. & Corey, L. Herpes simplex: insights on pathogenesis and possible vaccines. Annu. Rev. Med. 59, 381-395 (2008).
6. Woodland, D. L. & Kohlmeier, J. E. Migration, maintenance and recall ofmemory T cells in peripheral tissues. Nature Rev. Immunol. 9, 153-161 (2009).
7. Masopust, D. et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 207, 553-564 (2010).
8. Klonowski, K. D. et al. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 20, 551-562 (2004).
9. Groom, J. R. & Luster, A. D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207-215 (2011).
10. Mueller, S. N., Heath, W., McLain, J. D., Carbone, F. R. & Jones, C. M.Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol. Cell Biol. 80, 156-163 (2002).
11. Jones, C. A., Taylor, T. J. & Knipe, D. M. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model. Virology 278, 137-150 (2000).
12. Smith, C. M. et al. Cognate CD41 T cell licensing of dendritic cells in CD81 T cell immunity. Nature Immunol. 5, 1143-1148 (2004).
13. Kaech, S. M. & Wherry, E. J. Heterogeneity and cell-fate decisions in effector and memory CD81 T cell differentiation during viral infection. Immunity 27, 393-405 (2007).
14. Weninger, W., Crowley, M. A., Manjunath, N. & von Andrian, U. H. Migratory properties of naive, effector, and memory CD81 T cells. J. Exp. Med. 194, 953-966 (2001).
15. Gebhardt, T. et al. Different patterns of peripheral migration bymemoryCD41 and CD81 T cells. Nature 477, 216-219 (2011).
16. Zhu, J. et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanismfor increased HIV-1 acquisition. Nature Med. 15, 886-892 (2009).
17. Iijima, N. et al.Dendritic cellsandBcellsmaximizemucosal Th1memory response to herpes simplex virus. J. Exp. Med. 205, 3041-3052 (2008).
18. Parr, M. B. & Parr, E. L. Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites. J. Neurovirol. 9, 594-602 (2003).
19. Mackay, L. K. et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc. Natl Acad. Sci. USA 109, 7037-7042 (2012).
20. Khanna, K. M., Lepisto, A. J. & Hendricks, R. L. Immunity to latent viral infection: many skirmishes but few fatalities. Trends Immunol. 25, 230-234 (2004).
21. Perkins, N., Nisbet, M. & Thomas, M. Topical imiquimod treatment of aciclovirresistant herpes simplex disease: case series and literature review. Sex. Transm. Infect. 87, 292-295 (2011).
22. Gill, N., Davies, E. J. & Ashkar, A. A. The role of Toll-like receptor ligands/agonists in protection against genital HSV-2 infection. Am. J. Reprod. Immunol. 59, 35-43 (2008).
23. Iwasaki, A. Antiviral immune responses in the genital tract: clues for vaccines. Nature Rev. Immunol. 10, 699-711 (2010).
24. Gajewski, T. F., Fuertes, M., Spaapen, R., Zheng, Y. & Kline, J. Molecular profiling to identify relevant immuneresistancemechanismsin the tumor microenvironment. Curr. Opin. Immunol. 23, 286-292 (2011).
25. Parr, M. B. et al. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70, 369-380 (1994).
26. Spang, A. E., Godowski, P. J. & Knipe, D. M.Characterization of herpes simplex virus 2 temperature-sensitive mutants whose lesions map in or near the coding sequences for the major DNA-binding protein. J. Virol. 45, 332-342 (1983).